F
FirstString Research
FirstString Research | healing power
About FirstString Research
FirstString Research is a biopharmaceutical company specializing in the development of innovative therapies for wound healing and tissue regeneration. The company operates in the healthcare and biotechnology market, targeting patients with chronic wounds, surgical wounds, and other tissue repair needs. FirstString Research employs a business model focused on research and development, clinical trials, and partnerships with healthcare providers and pharmaceutical companies. Revenue is generated through the commercialization of its proprietary therapies, licensing agreements, and strategic collaborations. The company serves a diverse client base, including hospitals, clinics, and healthcare professionals, aiming to improve patient outcomes and quality of life.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Fort Worth, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 59.1/100
- Industry
- Health, Energy
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Apr 2021 | $27M | $107M | Undisclosed | — |
| SERIES COther financing | Apr 2019 | $12M | $75M | Undisclosed | — |
Growth signals
Latest recorded traffic for FirstString Research is 70 monthly website visits, down 74.1% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series B and later1 investor entered at this stage
- SMSophos Capital Management
Other known investors2 additional known investors
Medical University of South Carolina
Relief Therapeutics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about FirstString Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FirstString Research’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







